With 3.05 million shares changed hands, the volume of the stock remained lighter than its average volume of 4.8 million shares. During the session, the Uranium company that operates in wider Energy sector, reached to the highest price of $49.65 whereas the lowest price it dropped to was $48.29. The 52-week range on CCJ shows that it touched its highest point at $52.64 and its lowest point at $25.72 during that stretch. It currently has a 1-year price target of $55.33. With its current market cap of 21.43 billion, CCJ has annualized dividend of $0.09 while the current yield stands at 0.18%. Beta for the stock currently stands at 0.89.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CCJ was up-trending over the past week, with a rise of 2.60%, but this was up by 15.55% over a month. Three-month performance surged to 6.45% while six-month performance rose 25.73%. The stock gained 88.07% in the past year, while it has gained 14.50% so far this year. A look at the trailing 12-month EPS for CCJ yields 0.62 with Next year EPS estimates of 1.69. For the next quarter, that number is 0.25. This implies an EPS growth rate of 78.03% for this year and 63.66% for next year. EPS is expected to grow by 48.31% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 13.73%.
Float and Shares Shorts:
At present, 434.18 million CCJ shares are outstanding with a float of 432.96 million shares on hand for trading. On 2024-04-15, short shares totaled 21.37 million, which was 492.00001999999995 higher than short shares on 1710460800. In addition to Mr. Timothy S. Gitzel as the firm’s President, CEO & Director, Dr. Grant E. Isaac serves as its Executive VP & CFO.
Institutional Ownership:
Through their ownership of 0.73274004 of CCJ’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2023-12-31, CCJ reported revenue of $843717000.0 and operating income of $19164000.0. The EBITDA in the recently reported quarter was $126811000.0 and diluted EPS was $nan.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CCJ since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.
